DrugRepV_0415 | Tioconazole | Dermatologicals; Genito Urinary System and Sex Hormones | Vulvovaginal candidiasis (moniliasis) | Ebola virus | eGFP-EBOV | NA | Fluorescence-based assay | Decrease (50 %) | Approved | 26041706 |
DrugRepV_0906 | Sertaconazole | Dermatologicals; Genito Urinary System and Sex Hormones | Fungal infections (Tinea pedis) | Zika virus | MEX_I_7 | NA | Fluorescence-based assay | Decrease (54.215 %) | Approved, Investigational | 27476412 |
DrugRepV_2918 | Tioconazole | Dermatologicals; Genito Urinary System and Sex Hormones | Vulvovaginal candidiasis (moniliasis) | Chikungunya virus | vAc-CHIKV 26S-Rhir-E | NA | Fusion index-Fluorescent Intensities | Increase (-10.954794 %) | Approved | 27742486 |